Status:
COMPLETED
Plant Stanols and Type 1 Diabetes
Lead Sponsor:
Marjukka Kolehmainen
Collaborating Sponsors:
Kuopio University Hospital
Raisio Plc
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
18-72 years
Phase:
NA
Brief Summary
In type 1 diabetes (T1D) coronary artery disease (CAD) is an important cause of morbidity and mortality. Although serum cholesterol concentrations are not always elevated in T1D, cholesterol metabolis...
Detailed Description
In type 1 diabetes (T1D) coronary artery disease (CAD) is an important cause of morbidity and mortality. Although serum cholesterol concentrations are not always elevated in T1D, cholesterol metabolis...
Eligibility Criteria
Inclusion
- type 1 diabetes, stabile statin drug use, HbA1c \<9%
Exclusion
- liver, kidney and thyroid dysfunction, severe diabetic proteinuria, gastroparesis, unstable CAD, unstable inflammatory gastrointestinal disease
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01205308
Start Date
January 1 2010
End Date
March 1 2011
Last Update
April 17 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Eastern Finland
Kuopio, Finland, FIN-70211